Switch theme
Sign up to access all valuation multiples
Clinical Laserthermia Systems AB develops and sells single-use products used during each treatment procedure of treatment of solid tumors cancers. Its products include Thermal Therapy System, Mobile Laser Unit, Laser Applicator Non-cooled and Tissue Temp Probe.
2006
12
Last FY Revenue $1.9M
Last FY EBITDA -$4.6M
$4.9M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Clinical Laserthermia achieved revenue of $1.9M and an EBITDA of -$4.6M.
Clinical Laserthermia expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Clinical Laserthermia valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $1.9M | XXX | XXX | XXX |
| Gross Profit | XXX | $1.1M | XXX | XXX | XXX |
| Gross Margin | XXX | 55% | XXX | XXX | XXX |
| EBITDA | XXX | -$4.6M | XXX | XXX | XXX |
| EBITDA Margin | XXX | -238% | XXX | XXX | XXX |
| EBIT | XXX | -$5.6M | XXX | XXX | XXX |
| EBIT Margin | XXX | -289% | XXX | XXX | XXX |
| Net Profit | XXX | -$4.9M | XXX | XXX | XXX |
| Net Margin | XXX | -254% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Clinical Laserthermia's stock price is SEK 3 (or $0).
Clinical Laserthermia has current market cap of SEK 75.5M (or $7.8M), and EV of SEK 47.8M (or $4.9M).
See Clinical Laserthermia trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4.9M | $7.8M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Clinical Laserthermia has market cap of $7.8M and EV of $4.9M.
Clinical Laserthermia's trades at 2.5x EV/Revenue multiple, and -1.1x EV/EBITDA.
Equity research analysts estimate Clinical Laserthermia's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Clinical Laserthermia's P/E ratio is not available.
See valuation multiples for Clinical Laserthermia and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $7.8M | XXX | $7.8M | XXX | XXX | XXX |
| EV (current) | $4.9M | XXX | $4.9M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 2.5x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -1.1x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | -0.9x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -1.6x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -0.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialClinical Laserthermia's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.6M for the same period.
Clinical Laserthermia's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Clinical Laserthermia's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Clinical Laserthermia and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -238% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.6M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 344% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Clinical Laserthermia acquired XXX companies to date.
Last acquisition by Clinical Laserthermia was XXXXXXXX, XXXXX XXXXX XXXXXX . Clinical Laserthermia acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Clinical Laserthermia founded? | Clinical Laserthermia was founded in 2006. |
| Where is Clinical Laserthermia headquartered? | Clinical Laserthermia is headquartered in Sweden. |
| How many employees does Clinical Laserthermia have? | As of today, Clinical Laserthermia has 12 employees. |
| Is Clinical Laserthermia publicy listed? | Yes, Clinical Laserthermia is a public company listed on STO. |
| What is the stock symbol of Clinical Laserthermia? | Clinical Laserthermia trades under CLS B ticker. |
| When did Clinical Laserthermia go public? | Clinical Laserthermia went public in 2009. |
| Who are competitors of Clinical Laserthermia? | Similar companies to Clinical Laserthermia include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Clinical Laserthermia? | Clinical Laserthermia's current market cap is $7.8M |
| Is Clinical Laserthermia profitable? | Yes, Clinical Laserthermia is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
